204 related articles for article (PubMed ID: 15728220)
1. Platinums in lung cancer: sufficient or necessary?
Bunn PA
J Clin Oncol; 2005 May; 23(13):2882-3. PubMed ID: 15728220
[No Abstract] [Full Text] [Related]
2. Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.
Hotta K; Matsuo K; Ueoka H; Kiura K; Tabata M; Tanimoto M
J Clin Oncol; 2004 Oct; 22(19):3852-9. PubMed ID: 15326195
[TBL] [Abstract][Full Text] [Related]
3. Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?
Tiseo M; Boni L; Ardizzoni A
J Clin Oncol; 2005 Sep; 23(25):6276-7; author reply 6277-8. PubMed ID: 16135504
[No Abstract] [Full Text] [Related]
4. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
Jiang J; Liang X; Zhou X; Huang R; Chu Z
Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewed.
Azzoli CG; Kris MG; Pfister DG
J Natl Cancer Inst; 2007 Jun; 99(11):828-9. PubMed ID: 17551137
[No Abstract] [Full Text] [Related]
6. Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature.
D'Addario G; Pintilie M; Leighl NB; Feld R; Cerny T; Shepherd FA
J Clin Oncol; 2005 May; 23(13):2926-36. PubMed ID: 15728229
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
[TBL] [Abstract][Full Text] [Related]
8. [A meta-analysis of the curative effects of carboplatin-based and cisplatin-based chemotherapeutic regimens on advance non-small cell lung cancer].
Jiang JW; Liang XH; Zhou XL; Huang RF
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(37):2615-20. PubMed ID: 17198587
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy in non-small cell lung cancer: an update of an individual patient data-based meta-analysis.
Burdett S; Stewart L; Pignon JP
J Thorac Cardiovasc Surg; 2005 May; 129(5):1205; author reply 1205-6. PubMed ID: 15867822
[No Abstract] [Full Text] [Related]
10. NSCLC--platinum or not.
Androulakis N; Georgoulias V
Lung Cancer; 2005 Mar; 47(3):381-3. PubMed ID: 15713521
[No Abstract] [Full Text] [Related]
11. Multimodality management of regionally advanced non-small-cell lung cancer.
Belani CP
Semin Oncol; 1993 Aug; 20(4):302-14. PubMed ID: 8393590
[No Abstract] [Full Text] [Related]
12. Is there a standard regimen for first-line treatment of advanced/metastatic Non-Small-Cell Lung Cancer? What has meta-analyses contributed to today's standard of care.
Pallis AG; Georgoulias V
Lung Cancer; 2012 Mar; 75(3):269-74. PubMed ID: 21996086
[TBL] [Abstract][Full Text] [Related]
13. The future of adjuvant chemotherapy for resected non-small cell lung cancer.
Vansteenkiste JF; Schildermans RH
Expert Rev Anticancer Ther; 2005 Feb; 5(1):165-75. PubMed ID: 15757448
[TBL] [Abstract][Full Text] [Related]
14. Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure?
Socinski MA
J Clin Oncol; 2009 Jul; 27(20):3268-70. PubMed ID: 19470913
[No Abstract] [Full Text] [Related]
15. Evolution of non-small cell lung cancer chemotherapy (Review).
Dimitroulis J; Stathopoulos GP
Oncol Rep; 2005 May; 13(5):923-30. PubMed ID: 15809759
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy for non-small-cell lung cancer.
Pisters KM
Clin Adv Hematol Oncol; 2003 Sep; 1(9):533-7. PubMed ID: 16258445
[TBL] [Abstract][Full Text] [Related]
17. Platin or no platin? That is the question.
Schiller JH
J Clin Oncol; 2003 Aug; 21(16):3009-10. PubMed ID: 12837812
[No Abstract] [Full Text] [Related]
18. NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.
Wurstbauer K; Deutschmann H; Kopp P; Kranzinger M; Merz F; Nairz O; Studnicka M; Sedlmayer F
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():38-40. PubMed ID: 18167008
[No Abstract] [Full Text] [Related]
19. The ALPI Trial: the Italian/European experience with adjuvant chemotherapy in resectable non-small lung cancer.
Scagliotti GV
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5011s-5016s. PubMed ID: 16000605
[TBL] [Abstract][Full Text] [Related]
20. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
Früh M; Rolland E; Pignon JP; Seymour L; Ding K; Tribodet H; Winton T; Le Chevalier T; Scagliotti GV; Douillard JY; Spiro S; Shepherd FA
J Clin Oncol; 2008 Jul; 26(21):3573-81. PubMed ID: 18640938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
